CDIO · Cardio Diagnostics Holdings, Inc.

NasdaqHealthcareBiotechnology

Cardio Diagnostics Holdings Inc Is A Medical Technology Company Focused On Developing And Commercializing Epigenetics-Based Clinical Tests For Cardiovascular Diseases And Associated Comorbidities By Leveraging Its Artificial Intelligence (Ai)-Driven Multi-Omics Engine. The Company Has Developed Two Clinical Products: Epi+Gen Chd And Precisionchd, Epigenetics-Based Clinical Blood Tests Capable Of Assessing Risk For A Coronary Heart Disease (Chd) Event, Including Heart Attacks. Additionally, Its Portfolio Includes Heartrisk, A Cardiovascular Disease Risk Intelligence Platform, And Cardioinnovate360, A Research-Use-Only Solution Launched To Support The Discovery, Development, And Validation Of Novel Biopharmaceuticals For The Assessment And Management Of Cardiovascular Diseases.

HealthcareNasdaqUSVery Low Float

FLOAT

2.7M

FREE FLOAT %

90%

SHARES O/S

3.0M

MARKET CAP

$5.0M

EXCHANGE

Nasdaq

COUNTRY

CDIO Catalyst History

No catalysts recorded for CDIO yet

Day Trader Sniper hasn't classified a publishable catalyst for CDIO yet. New events appear here as they're scored.

Be early on the next CDIO spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

CDIO · Cardio Diagnostics Holdings, Inc.

CDIO Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.